Also trades as: LSB (NASDAQ) · $vol 0M
LSBCF OTC
LakeShore Biopharma Co., Ltd
1W: +29.7%
1M: +60.0%
3M: -62.9%
YTD: -94.3%
1Y: -95.8%
3Y: -99.7%
$0.07
+0.02 (+40.00%)
Weekly Expected Move ±33.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.9M
52W Range0.0278-1.48
Volume0
Avg Volume5,041
Beta0.11
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOWang Xu
Employees758
SectorHealthcare
IndustryBiotechnology
IPO Date2021-08-05
Websiteysbiopharm.com
Building No. 2
Beijing 102629
CN
Beijing 102629
CN
86 10 8920 2086
About LakeShore Biopharma Co., Ltd
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
Recent Insider Trades
No insider trades found